QS Investors’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-20,683
| Closed | -$195K | – | 1290 |
|
|
2020
Q3 | $195K | Sell |
20,683
-75,802
| -79% | -$720K | ﹤0.01% | 1079 |
|
|
2020
Q2 | $739K | Hold |
96,485
| – | – | 0.01% | 817 |
|
|
2020
Q1 | $597K | Buy |
96,485
+800
| +0.8% | +$7.05K | 0.01% | 795 |
|
|
2019
Q4 | $1.18M | Sell |
95,685
-1,750
| -2% | -$19.1K | 0.01% | 739 |
|
|
2019
Q3 | $1.13M | Hold |
97,435
| – | – | 0.01% | 753 |
|
|
2019
Q2 | $974K | Sell |
97,435
-2,050
| -2% | -$22.1K | 0.01% | 802 |
|
|
2019
Q1 | $1.28M | Hold |
99,485
| – | – | 0.01% | 746 |
|
|
2018
Q4 | $1.51M | Hold |
99,485
| – | – | 0.02% | 658 |
|
|
2018
Q3 | $1.99M | Hold |
99,485
| – | – | 0.02% | 629 |
|
|
2018
Q2 | $1.94M | Buy |
99,485
+13
| +0% | +$288 | 0.02% | 617 |
|
|
2018
Q1 | $2M | Sell |
99,472
-6,813
| -6% | -$115K | 0.02% | 581 |
|
|
2017
Q4 | $1.41M | Sell |
106,285
-3,613
| -3% | -$54.5K | 0.01% | 714 |
|
|
2017
Q3 | $2.03M | Buy |
109,898
+12,997
| +13% | +$242K | 0.02% | 605 |
|
|
2017
Q2 | $1.78M | Sell |
96,901
-12,200
| -11% | -$242K | 0.02% | 620 |
|
|
2017
Q1 | $2.46M | Sell |
109,101
-144,400
| -57% | -$3.46M | 0.02% | 537 |
|
|
2016
Q4 | $8.82M | Buy |
253,501
+55,580
| +28% | +$1.66M | 0.07% | 202 |
|
|
2016
Q3 | $4.85M | Sell |
197,921
-78
| -0% | -$1.95K | 0.04% | 379 |
|
|
2016
Q2 | $4.74M | Buy |
197,999
+57,200
| +41% | +$1.31M | 0.04% | 401 |
|
|
2016
Q1 | $3.29M | Hold |
140,799
| – | – | 0.03% | 514 |
|
|
2015
Q4 | $4.25M | Sell |
140,799
-3,679
| -3% | -$119K | 0.04% | 450 |
|
|
2015
Q3 | $5.74M | Buy |
144,478
+40,578
| +39% | +$2.52M | 0.06% | 304 |
|
|
2015
Q2 | $7.17M | Hold |
103,900
| – | – | 0.09% | 276 |
|
|
2015
Q1 | $5.68M | Sell |
103,900
-50,200
| -33% | -$2.39M | 0.06% | 335 |
|
|
2014
Q4 | $6.57M | Buy |
+154,100
| New | +$5.57M | 0.08% | 286 |
|
QS Investors's AMAG Position: Q4 2020 in Review
QS Investors sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 20,683 shares — an estimated $195K sold.
QS Investors first reported a position in AMAG in Q4 2014 and held it in 24 quarters. The position peaked at $8.82M in Q4 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- QS Investors reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- QS Investors sold 20,683 AMAG Pharmaceuticals shares in Q4 2020, an estimated $195K.
- QS Investors first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 24 quarters.
- QS Investors's AMAG Pharmaceuticals position peaked at $8.82M in Q4 2016.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on QS Investors's 13F filing for Q4 2020, filed 10 Feb 2021.